文献速递疼痛医学

血栓素A2受体激动剂对小鼠多种疼痛模型的镇痛作用

Analgesic Effect of a Thromboxane A 2 Receptor Agonist on Multiple Pain Models in Mice.
PubMed 文献 · Anesth Analg · 2026-04-24

该研究在小鼠四种疼痛模型中评估鞘内注射血栓素A2受体(TPR)激动剂I-BOP的镇痛效果。结果显示I-BOP在PGE2诱导的异常性疼痛、L5脊神经切断神经痛及福尔马林试验第二时相中产生剂量依赖性镇痛,且脊髓背角TPR表达上调,提示TPR信号参与疼痛调控。

要点

  • 鞘内I-BOP在PGE2诱导异常性疼痛模型呈剂量依赖性镇痛。
  • L5-SNT神经痛模型中I-BOP剂量依赖性提高机械缩足阈值。
  • 福尔马林试验中I-BOP选择性减少第二时相伤害性行为。

核心结论

  • TPR激动剂I-BOP通过作用于脊髓TPR产生镇痛效应,提示TPR信号参与疼痛调控。

研究设计与样本

  • 四週龄雄性ddY小鼠,每组n=6-10,鞘内给予TPR激动剂I-BOP,在热板、福尔马林、PGE2诱导异常性疼痛及L5脊神经切断四种疼痛模型中行行为学测试。
  • 采用RT-PCR分析脊髓背角COX-1、COX-2、TXAS及TPR mRNA表达,免疫组化定位TPR。

主要发现

  • L5-SNT小鼠同侧脊髓背角TPR mRNA表达增加,免疫组化显示TPR定位于脊髓背角胶状质及深层。

临床怎么用

  • 动物实验提示脊髓TPR信号可能成为疼痛调控的潜在靶点,尚需临床研究验证。

局限性

  • 研究仅使用雄性ddY小鼠,未涉及雌性及临床人群,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thromboxane A 2 (TXA 2 ), a metabolite of arachidonic acid, is well known for its role in vasoconstriction and platelet aggregation via activation of thromboxane prostanoid receptors (TPR). Although other prostanoid receptors have established roles in pain modulation, the contribution of TXA 2 -TPR signaling to nociceptive processing remains unclear. This study evaluated the analgesic effects of a TPR agonist in mouse models of pain. METHODS: Four-week-old male ddY mice, an outbred mouse strain, received intrathecal (i.t.) administration of (Z)-7-((1S,2R,3R,4R)-3-((R,E)-3-hydroxy-4-(4-iodophenoxy)but-1-en-1-yl)-7-oxabicyclo[2.2.1]heptan-2-yl)hept-5-enoic acid (I-BOP), a TPR agonist, in four pain models (n = 6-10 per group): hot plate test, formalin test, prostaglandin E 2 (PGE 2 )-induced allodynia, and L5 spinal nerve transection (L5-SNT). Behavioral tests evaluated pain responses as the primary outcome. The mRNA expression levels of cyclooxygenase (COX)-1, COX-2, TXA 2 synthase (TXAS), and TPR were analyzed by reverse transcription-polymerase chain reaction and compared between ipsilateral and contralateral L4-L6 spinal dorsal horns. TPR localization in the spinal dorsal horn was determined by immunohistochemistry. Data were analyzed using appropriate parametric or nonparametric tests based on the results of normality assessment. Comparisons between groups were performed using Student t test, the Mann-Whitney U test, 1-way analysis of variance (ANOVA) with Dunnett post hoc test, 2-way ANOVA with Bonferroni post hoc test, or Friedman test followed by Wilcoxon signed-rank tests with Bonferroni correction as appropriate. All behavioral assessments were conducted in a blinded manner. RESULTS: In the PGE 2 -induced allodynia model, coadministration of I-BOP dose dependently reduced the allodynia score compared with PGE 2 alone. When the response to PGE 2 alone was defined as 100%, the allodynia scores were reduced to 20% (95% confidence interval [CI], -7 to 47; P = .0012) at 1 ng and 10% (95% CI, -11 to 31; P < .001) at 10 ng I-BOP. In the L5-SNT neuropathic pain model, i.t. I-BOP produced a dose-dependent elevation of mechanical withdrawal thresholds, with significant main effects of dose ( P < .001) and time ( P < .001) and a significant dose × time interaction ( P = .0012). In the formalin test, I-BOP selectively reduced nociceptive behavior during the second phase (I-BOP 140 ± 6.2 seconds; saline 623 ± 18.1 seconds, expressed as mean ± standard error of the mean [SEM]; P = .008), without affecting the first phase. The ipsilateral spinal dorsal horn of L5-SNT mice showed increased TPR mRNA expression. Immunohistochemistry revealed TPR localization in both the substantia gelatinosa and deep laminae of the spinal dorsal horn. CONCLUSIONS: These findings suggest that a TPR agonist exerts analgesic effects by acting on TPR expressed in the spinal cord, highlighting the potential role of TPR signaling in pain modulation.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Fujiwara A, Ueno T, Matsumura S, et al. Analgesic Effect of a Thromboxane A 2 Receptor Agonist on Multiple Pain Models in Mice. Anesth Analg. 2026. PMID: 42030527. doi:10.1213/ANE.0000000000008045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。